Farideh Alasti - Concepedia

Author

Farideh Alasti

Medical University of Vienna

Also Known As

D. Aletaha, F Alasti, F. Alasti, Farideh Alasti, Farideh Mohammadi Alasti, ف. الستی

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Medical University of Vienna Klinik Hietzing Boston University European League Against Rheumatism Statistics Austria

About

Farideh Alasti is an author at Medical University of Vienna specializing in orthopaedics, rheumatology, and rheumatic diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Orthopaedics	2	2	54
3	Rheumatology	2	2	54
4	Physical Therapy	1	1	24
5	Rehabilitation	1	1	24

Farideh Alasti

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score Monika Schoels, Daniel Aletaha, Farideh Alasti, Annals of the Rheumatic Diseases	2015	468
American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision Paul Studenic, Daniel Aletaha, Maarten de Wit, Annals of the Rheumatic Diseases	2022	119
Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials Daniel Aletaha, Farideh Alasti, Josef S Smolen Arthritis Research & Therapy	2015	105
Risk profiling for a refractory course of rheumatoid arthritis Manuel Bécède, Farideh Alasti, Irina Gessl, Seminars in Arthritis and Rheumatism	2019	97
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity Daniel Aletaha, Farideh Alasti, Josef S Smolen Annals of the Rheumatic Diseases	2012	91
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression Daniel Aletaha, Farideh Alasti, JS Smolen Annals of the Rheumatic Diseases	2016	85
Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point Daniel Aletaha, Farideh Alasti, Josef S Smolen Annals of the Rheumatic Diseases	2015	80
Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition Monika Schoels, Farideh Alasti, Josef S Smolen, Arthritis Research & Therapy	2017	71
Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis Daniela Sieghart, Alexander Platzer, Paul Studenic, Frontiers in Immunology	2018	70
American College of Rheumatology/<scp>EULAR</scp> Remission Criteria for Rheumatoid Arthritis: 2022 Revision Paul Studenic, Daniel Aletaha, Maarten de Wit, Arthritis & Rheumatology	2022	66

Page 1